null Two American Heart Association awards for RI-MUHC research associate
Livia Camargo, PhD, investigates human hypertension in Dr. Rhian Touyz’s laboratory
Livia Camargo, PhD, a research associate in the Cardiovascular Health Across the Lifespan Program at the Research Institute of the McGill University Health Centre (RI-MUHC), received two awards at the American Heart Association’s Hypertension Scientific Sessions held in San Diego, U.S., in September.
Her abstract titled “Nox5 Regulates Vascular Smooth Muscle Cell De-differentiation In Human Hypertension” won the Paul Dudley White International Scholar Award for the highest ranked abstract from Canada submitted to the meeting. Named for Dr. Paul Dudley White, a founding father of the American Heart Association and an early leader in preventive cardiology, this award reflects Dr. White’s vision for global excellence in cardiovascular science and medicine.
She also received the Trainee Advocacy Committee Early Career Oral Award. Judged on the quality of the presentation, importance/impact of the project in the field of hypertension research, and on methodological rigour, her abstract was one of six selected for presentation in a special session.
A member of Dr. Rhian Touyz’s laboratory at the RI-MUHC, Livia Camargo conducts research on oxidative stress in hypertension, focusing on identification of protein targets of oxidation. In the present study, she provided new insights into the proteomic changes related to vascular phenotype in hypertension and demonstrated that Nox5 plays an important role in vascular smooth muscle cells phenotypic switching associated with vascular dysfunction in hypertension. Identification of molecular mechanisms underlying oxidative stress will contribute to development of novel therapeutic strategies to improve treatment of hypertension and other cardiovascular diseases.
Please join us in congratulating Livia Camargo on this well-deserved award.
November 2, 2022